Read More 1 minute read Funding News News LTZ Therapeutics Secures Over $20 Million in Series A Financing to Advance Myeloid Engager Pipeline Key Highlights LTZ Therapeutics completes $20 million Series A financing led by Lapam Capital and GL Ventures. Total funding… byChris-Anne RoqueAugust 5, 2024